Fri, Mar 5th, 2021
Subscribe
Log In
Lists
Book of Lists
The Money Issue
LA500
Wealthiest Angelenos
Health Care
Real Estate
Finance
Manufacturing
Tech
Infrastructure
Travel/Leisure
Media
Professional Services
Events
2021 Events
2020 Events
2019 Events
Custom Features
Custom Content
Trusted Advisors
People on the Move
Companies on the Move
Videos
×
Los Angeles Business Journal
Orange County Business Journal
San Diego Business Journal
San Fernando Valley Business Journal
Subscribe
Follow
Follow our NEWS
Facebook
Twitter
Instagram
LinkedIn
Follow our EVENTS
Facebook
Twitter
Instagram
Email Alerts
Log In
Search
×
Friday, March 05, 2021
Fri, Mar 5th, 2021
Subscribe
Log In
Lists
Book of Lists
The Money Issue
LA500
Wealthiest Angelenos
Health Care
Real Estate
Finance
Manufacturing
Tech
Infrastructure
Travel/Leisure
Media
Professional Services
Events
2021 Events
2020 Events
2019 Events
Custom Features
Custom Content
Trusted Advisors
People on the Move
Companies on the Move
Videos
Home
Kresa, Kent — MannKind Corp
Chairman
MannKind Corp.
THE LATEST:&MannKind, which has focused on the development of inhaled therapeutic products, announced in March that it is adjusting research and development resources to focus on respiratory viral infections such as Covid-19. The shift comes after the strongest quarter in company history for its inhaled insulin product Afrezza, which generated nearly $8 million in sales. Kresa in January sold for $37 million, to an unidentified party, the Beverly Hills mansion he developed.
BACKGROUND: Kresa, a former chief executive and chairman of Northrop Grumman Corp., joined MannKind's board in 2004 and was named chairman in 2016. The Westlake Village-based biopharmaceutical company develops therapeutic products for the treatment of diabetes and pulmonary arterial hypertension. Kresa is chairman of the advisory board of Lincoln Laboratory at the Massachusetts Institute of Technology, his alma mater. He is also a member of the board of overseers at Keck School of Medicine of USC and chairman emeritus of the Caltech board of trustees.
YEARS ON THE LA500: 5
Return to the 2020 edition of the LA500.